Retatrutide has not been approved by the FDA, but precisely one 79-year-old man was granted access via "compassionate use."

Questions are swirling over Donald Trump’s health after a bombshell report revealed a mystery man was getting unprecedented access to a weight-loss drug.

A bombshell report about how a 79-year-old man got early access to a weight loss drug has all eyes on the president.